Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ).

Pouplard C, Galinat H, Ternisien C, Blanc Jouvan F, De Maistre E, Duchemin J, Flaujac C, Hézard N, Grand F, Le Cam-Duchez V, Marlu R, Mourey G, Nedelec F, Pineau-Vincent F, Repesse Y, Stépanian A, Szymezak J, Voisin S, Voyer AL, Jeanpierre E, Lasne D; French Study Group on Laboratory Management of bleeding disorders (BIMHO group).

Haemophilia. 2019 Sep;25(5):e327-e330. doi: 10.1111/hae.13812. Epub 2019 Jul 11. No abstract available.

PMID:
31294887
2.

Prednisolone treatment induced temporary factor IX normalization in mild hemophilia B who required an epidural infiltration: A case report.

Carrette M, Feugray G, Chamouni P, Le Cam Duchez V, Fretigny M, Barbay V, Billoir P.

Transfus Apher Sci. 2019 Aug;58(4):512-514. doi: 10.1016/j.transci.2019.05.009. Epub 2019 Jun 28.

PMID:
31272859
3.

Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?

Billoir P, Clavier T, Guilbert A, Barbay V, Chrétien MH, Fresel M, Abriou C, Girault C, Le Cam Duchez V.

J Thromb Thrombolysis. 2019 Aug;48(2):277-283. doi: 10.1007/s11239-019-01882-1.

PMID:
31098816
4.

[Which place of antiphosphatidylethanolamine antibodies research in seronegative antiphospholipid syndrome suspicion?]

Billoir P, Miranda S, Abboud J, Armengol G, Levesque H, Benhamou Y, Le Cam Duchez V.

Rev Med Interne. 2019 Jun;40(6):351-354. doi: 10.1016/j.revmed.2018.11.013. Epub 2019 Mar 21. French.

PMID:
30905593
5.

Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction.

Miranda S, Billoir P, Damian L, Thiebaut PA, Schapman D, Le Besnerais M, Jouen F, Galas L, Levesque H, Le Cam-Duchez V, Joannides R, Richard V, Benhamou Y.

PLoS One. 2019 Mar 14;14(3):e0212614. doi: 10.1371/journal.pone.0212614. eCollection 2019.

6.

Factor VIII assays in treated hemophilia A patients.

Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E; groupe d'études de la biologie des maladies hémorragiques du Groupe français d'études de l'hémostase et la thrombose.

Ann Biol Clin (Paris). 2019 Feb 1;77(1):53-65. doi: 10.1684/abc.2019.1413. Review.

PMID:
30799298
7.

Factor IX assays in treated hemophilia B patients.

Pouplard C, Jeanpierre E, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Ternisien C, Toulon P, Voisin S, Nougier C; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose.

Ann Biol Clin (Paris). 2019 Feb 1;77(1):41-52. doi: 10.1684/abc.2019.1414. Review.

PMID:
30799297
8.

Thrombin generation profile in non-thrombotic factor V Leiden carriers.

Billoir P, Duflot T, Fresel M, Chrétien MH, Barbay V, Le Cam Duchez V.

J Thromb Thrombolysis. 2019 Apr;47(3):473-477. doi: 10.1007/s11239-019-01821-0.

PMID:
30701464
9.

Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.

Billoir P, Barbay V, Joly LM, Fresel M, Chrétien MH, Le Cam Duchez V.

Ann Pharmacother. 2019 Apr;53(4):341-347. doi: 10.1177/1060028018811657. Epub 2018 Oct 31.

PMID:
30378443
10.

Management of dabigatran after overdosage: two case reports and suggestions for monitoring.

Billoir P, Girault C, Barbay V, Boyer D, Grangé S, Fresel M, Chrétien MH, Le Cam Duchez V.

Blood Coagul Fibrinolysis. 2018 Nov;29(7):653-655. doi: 10.1097/MBC.0000000000000763.

PMID:
30045050
11.

Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies.

Billoir P, Miranda S, Damian L, Richard V, Benhamou Y, Le Cam Duchez V.

Thromb Res. 2018 Sep;169:87-92. doi: 10.1016/j.thromres.2018.07.021. Epub 2018 Jul 17.

PMID:
30031291
12.

Thrombin generation test as a marker for high risk venous thrombosis pregnancies.

Joly BS, Sudrié-Arnaud B, Barbay V, Borg JY, Le Cam Duchez V.

J Thromb Thrombolysis. 2018 Jan;45(1):114-121. doi: 10.1007/s11239-017-1572-3.

PMID:
29032523
13.

Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study.

Miranda S, Le Cam-Duchez V, Benichou J, Donnadieu N, Barbay V, Le Besnerais M, Delmas FX, Cuvelier A, Lévesque H, Benhamou Y, Armengol G.

Thromb Res. 2017 Jul;155:1-5. doi: 10.1016/j.thromres.2017.04.011. Epub 2017 Apr 12.

PMID:
28460259
14.

Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples.

Caron C, Meley R, Le Cam Duchez V, Aillaud MF, Lavenu-Bombled C, Dutrillaux F, Flaujac C, Ryman A, Ternisien C, Lasne D, Galinat H, Pouplard C.

Int J Lab Hematol. 2017 Jun;39(3):279-285. doi: 10.1111/ijlh.12621. Epub 2017 Mar 20.

PMID:
28318109
15.

[Acquired A hemophilia and lymphoproliferative diseases: A literature review].

Le Cam-Duchez V.

Rev Med Interne. 2015 Dec;36(12):834-9. doi: 10.1016/j.revmed.2015.09.004. Epub 2015 Oct 23. Review. French.

PMID:
26481810
16.

Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis.

Banse C, Benhamou Y, Lequerré T, Le Cam-Duchez V, Lévesque H, Vittecoq O.

Joint Bone Spine. 2015 May;82(3):200-2. doi: 10.1016/j.jbspin.2014.12.003. Epub 2015 Jan 20.

PMID:
25617259
17.

Comparative study of the effect of rivaroxaban and fondaparinux on monocyte's coagulant activity and cytokine release.

Laurent M, Joimel U, Varin R, Cazin L, Gest C, Le-Cam-Duchez V, Jin J, Liu J, Vannier JP, Lu H, Soria J, Li H, Soria C.

Exp Hematol Oncol. 2014 Dec 17;3(1):30. doi: 10.1186/2162-3619-3-30. eCollection 2014.

18.

Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke.

Joly B, Menard AL, Ozkul-Wermester O, Triquenot-Bagan A, Guegan-Massardier E, Borg JY, Le Cam-Duchez V.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):916-7. doi: 10.1097/MBC.0000000000000165. No abstract available.

PMID:
25360683
19.

Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome.

Benhamou Y, Bellien J, Armengol G, Brakenhielm E, Adriouch S, Iacob M, Remy-Jouet I, Le Cam-Duchez V, Monteil C, Renet S, Jouen F, Drouot L, Menard JF, Borg JY, Thuillez C, Boyer O, Levesque H, Richard V, Joannidès R.

Arthritis Rheumatol. 2014 Nov;66(11):3210-20. doi: 10.1002/art.38785.

20.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

21.
22.

Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.

Joly B, Barbay V, Borg JY, Le Cam-Duchez V.

Thromb Res. 2013 Sep;132(3):386-91. doi: 10.1016/j.thromres.2013.07.022. Epub 2013 Aug 2.

PMID:
23962423
23.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S.

Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.

24.

Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry.

Borg JY, Guillet B, Le Cam-Duchez V, Goudemand J, Lévesque H; SACHA Study Group.

Haemophilia. 2013 Jul;19(4):564-70. doi: 10.1111/hae.12138. Epub 2013 Apr 10.

PMID:
23574453
25.

Algorithms using clinical and genetic data (CYP2C9, VKORC1) are relevant to predict warfarin dose in patients with different INR targets.

Le Cam-Duchez V, Frétigny M, Cailleux N, Gandelin C, Lévesque H, Borg JY.

Thromb Res. 2010 Sep;126(3):e235-7. doi: 10.1016/j.thromres.2010.05.003. Epub 2010 May 31. No abstract available.

PMID:
20569971
26.

[Protein Z, polymorphisms in the protein Z gene and thrombosis].

Le Cam-Duchez V, Barbay V, Soria C, Borg JY.

Rev Med Interne. 2010 Aug;31(8):551-7. doi: 10.1016/j.revmed.2009.04.013. Epub 2010 Apr 22. French.

PMID:
20416992
27.

Factor v Leiden homozygous genotype and pregnancy outcomes.

Biron-Andréani C, Bauters A, Le Cam-Duchez V, Delahousse B, Lequerrec A, Dutrillaux F, Boinot C, Saladin-Thiron C, Polack B, Gruel Y, Morange PE; PROCARE-GEHT Group.

Obstet Gynecol. 2009 Dec;114(6):1249-53. doi: 10.1097/AOG.0b013e3181c2243d.

PMID:
19935026
28.

Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level.

Le Cam-Duchez V, Soria C, Dit Sollier CB, Borg JY, Coudert M, Montalescot G, Esposito G, Drouet L, Collet JP.

Thromb Haemost. 2009 Jul;102(1):131-6. doi: 10.1160/TH09-01-0007.

PMID:
19572077
29.

[Anticoagulation clinics for outpatients: a 5-year experience].

Benhamou Y, Le Cam-Duchez V, Schneller JM, Cailleux N, Magne JC, Soubrane JC, Borg JY, Lévesque H.

Rev Med Interne. 2009 Jul;30(7):567-72. doi: 10.1016/j.revmed.2009.02.004. Epub 2009 Mar 18. French.

PMID:
19299042
30.

Haplotypic or genotypic combinations of three protein Z polymorphisms influence protein Z plasma level.

Le Cam-Duchez V, Barbay V, Bal Dit Sollier C, Drouet L, Coudert M, Soria C, Borg JY.

Thromb Haemost. 2009 Jan;101(1):212-4. No abstract available.

PMID:
19132212
31.

The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosis.

Le Cam-Duchez V, Bagan-Triquenot A, Barbay V, Mihout B, Borg JY.

J Neurol. 2008 Oct;255(10):1521-5. doi: 10.1007/s00415-008-0958-8. Epub 2008 Jul 31.

PMID:
18677630
32.

Factor V Cambridge mutation and activated protein C resistance assays.

Le Cam-Duchez V, Chrétien MH, Saugier-Veber P, Borg JY.

Thromb Haemost. 2006 Mar;95(3):581-3. No abstract available.

PMID:
16525593
33.

Serum erythropoietin levels in septic shock.

Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand G.

Anaesth Intensive Care. 2005 Oct;33(5):578-84.

34.

Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis.

Le Cam-Duchez V, Bagan-Triquenot A, Ménard JF, Mihout B, Borg JY.

Blood Coagul Fibrinolysis. 2005 Oct;16(7):495-500.

PMID:
16175009
35.

Erythropoietin and renin as biological markers in critically ill patients.

Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand G.

Crit Care. 2004 Oct;8(5):R328-35. Epub 2004 Aug 9.

36.

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

Giansily-Blaizot M, Verdier R, Biron-Adréani C, Schved JF, Bertrand MA, Borg JY, Le Cam-Duchez V, Briquel ME, Chambost H, Pouymayou K, Dutrillaux F, Favier R, Martin-Toutain I, Verdy E, Gay V, Goudemand J, Navarro R, Durin A, d'Oiron R, Lambert T, Pernod G, Barrot C, Peynet J, Bastenaire B, Sie P, Stieltjes N, Torchet MF, de Moerloose P; Study group of FVII deficiency.

Haematologica. 2004 Jun;89(6):704-9. Erratum in: Haematologica. 2007 Nov;92(11):1584. LeCam-Duchez, V [corrected to Le Cam-Duchez, V].

37.

Thrombophilia and fetal growth restriction.

Verspyck E, Borg JY, Le Cam-Duchez V, Goffinet F, Degré S, Fournet P, Marpeau L.

Eur J Obstet Gynecol Reprod Biol. 2004 Mar 15;113(1):36-40.

PMID:
15036708
38.

Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants.

Verspyck E, Le Cam-Duchez V, Goffinet F, Tron F, Marpeau L, Borg JY.

BJOG. 2002 Jan;109(1):28-33.

39.

Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.

Guédon C, Le Cam-Duchez V, Lalaude O, Ménard JF, Lerebours E, Borg JY.

Am J Gastroenterol. 2001 May;96(5):1448-54.

PMID:
11374681
40.

[Inherited thrombophilia and pregnancy].

Verspyck E, Le Cam-Duchez V, Borg JY, Marpeau L.

J Gynecol Obstet Biol Reprod (Paris). 2000 May;29(3):227-9. Review. French.

41.

Mesenteric venous thrombosis revealing both factor II G20212A mutation and hyperhomocysteinemia related to pernicious anemia.

Marie I, Levesque H, Le Cam-Duchez V, Borg JY, Ducrotté P, Philippe C.

Gastroenterology. 2000 Jan;118(1):237-8. No abstract available.

PMID:
10644179
42.

Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation.

Le Cam-Duchez V, Gandrille S, Trégouët D, Alhenc-Gelas M, Emmerich J, Fiessinger JN, Borg JY, Aiach M.

Br J Haematol. 1999 Sep;106(4):889-97.

PMID:
10519989
43.

Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A).

Verspyck E, Le Cam-Duchez V, Gravier A, Descargues G, Marpeau L, Borg JY.

Eur J Obstet Gynecol Reprod Biol. 1999 Apr;83(2):143-4.

PMID:
10391523
44.

Erythropoietin blood level is increased in sudden infant death.

Le Cam-Duchez V, Coquerel A, Chevallier F, Vaz E, Menard J, Basset C, Lahary A, Vannier JP.

Biol Neonate. 1999 Jul;76(1):1-9.

PMID:
10364633
45.

The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilic families.

Alhenc-Gelas M, Le Cam-Duchez V, Emmerich J, Frebourg T, Fiessinger JN, Borg JY, Aiach M.

Blood. 1997 Aug 15;90(4):1711. No abstract available.

PMID:
9269794

Supplemental Content

Loading ...
Support Center